Diagnostic accuracy of cytokine levels (TNF-α, IL-2 and IFN-γ) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients

Respiration

Volumn 75, Issue 1, 2008, Pages 73-78

  Küpeli, Elif ^a   Karnak, Demet ^a   Beder, Sumru ^a   Kayacan, Oya ^a   Tutkak, Hüseyin ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Bronchoalveolar lavage fluid; IFN ; IL 2; TNF ; Tuberculosis

Indexed keywords

ALBUMIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG LAVAGE; LUNG LOBE; LUNG TUBERCULOSIS; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; SMEAR;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPUTUM; STATISTICS, NONPARAMETRIC; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38049062581     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110744     Document Type: Article

References (38)

1. Fishman JA: Mycobacterial infections;in Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM (eds): Fishman's Manual of Pulmonary Diseases and Disorders, ed 3. New York, McGraw-Hill, 2002, pp 763-819.
2. Flynn JL, Chan J: Immunology of tuberculosis. Annu Rev Immunol 2001;19: 93-129.
3. Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, Nelwan RH, Marzuki S, van der Meer JW, van Crevel R, van de Vosse E, Ottenhoff TH: Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007;75:820-829.
4. Belli F, Capra A, Moraiti A, Rossi S, Rossi P: Cytokines assay in peripheral blood and bronchoalveolar lavage in the diagnosis and staging of pulmonary granulomatous diseases. Int J Immunopathol Pharmacol 2000;13:61-67.
5. Somoskovi A, Zissel G, Zipfel PF, Ziegenhagen MW, Klaucke J, Haas H, Schlaak M, Muller-Quernheim J: Different cytokine patterns correlate with extension of disease in pulmonary tuberculosis. Eur Cytokine Netw 1999;10:135-142.
6. Tsao TC, Huang CC, Chiou WK, Yang PY, Hsieh MJ, Tsao KC: Levels of interferon-gamma and interleukin-2-receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis 2002;6:720-727.
7. Vankayalapati R, Wizel B, Weis SE, Klucar P, Shams H, Samten B, Barnes PF: Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 2003;36:24-28.
8. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ: Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999;162:3504-3511.
9. Dlugovitzky D, Torres-Morales A, Rateni L, Farroni MA, Largacha C, Molteni O, Bottasso O: Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol 1997;18:203-207.
10. Conover WJ (ed): Practical Nonparametric Statistics, ed 2. New York, Wiley, 1980, chap 5, pp 229-239.
11. Karnak D, Beder S, Kayacan O, Ibis E, Oflaz G: Neuron-specific enolase and lung cancer. Am J Clin Oncol 2005;28:586-590.
12. Deveci F, Akbulut HH, Turgut T, Muz MH: Changes in serum cytokine levels in active tuberculosis with treatment. Mediators Inflamm 2005;5:256-262.
13. Gerosa F, Nisii C, Righetti S, Micciolo R, Marchesini M, Cazzadori A, Trinchieri G: CD4+ T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol 1999;92:224-234.
14. Tsao TC, Hong J, Huang C, Yang P, Liao SK, Chang KS: Increased TNF-α, IL-1β and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber Lung Dis 1999;79:279-285.
15. Tsao TC, Hong J, Li LF, Hsieh MJ, Liao SK, Chang KS: Imbalances between tumor necrosis factor-α and its soluble receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 2000;117:103-109.
16. Tsao TCY, Li LF, Hsieh M, Liao S, Chang KS: Soluble TNF-α receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary tuberculosis. Eur Respir J 1999;14:490-495.
17. Tahhan M, Ugurman F, Gozu A, Akkalyoncu B, Samurkasoglu B: Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritis. Respiration 2003;70:270-274.
18. Condos R, Rom WN, Liu YM, Schulger NW: Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 1998;157:729-735.
19. Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, Rom WN: Increased release of interleukin-1β, interleukin-6 and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153:799-804.
20. Theilmann L, Meyer U, Kommerell B, Dierkesmann R, Moller A: Alpha tumor necrosis factor in the serum of patients with sarcoidosis, tuberculosis or bronchial cancer (in German). Pneumologie 1990;44:735-738.
21. Chyczewska E, Mroz RM, Kowal E: TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC). Rocz Akad Med Bialymst 1997;42(suppl 1):123-135.
22. Georgiades G, Myrianthefs P, Venetsanou K, Kyroudi A, Kittas C, Baltopoulos G: Temperature and serum proinflammatory cytokine changes in patients with NSCLC after BAL. Lung 2003;181:35-47.
23. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Pathogenesis, Pathology and Pathophysiology. Bethesda, National Institutes of Health, 2001, chap 4, pp 28-43.
24. Matanic D, Beg-Zec Z, Stojanovic D, Matakoric N, Flego V, Milevoj-Ribic F: Cytokines in patients with lung cancer. Scand J Immunol 2003;57:173-178.
25. Mo XY, Sarawar SR, Doherty PC: Induction of cytokines in mice with parainfluenza pneumonia. J Virol 1995;69:1288-1291.
26. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM: Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993;178:2243-2247.
27. Pearl JE, Saunders B, Ehlers S, Orme IM, Cooper AM: Inflammation and lymphocyte activation during mycobacterial infection in the interferon-γ deficient mouse. Cell Immunol 2001;211:43-50.
28. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, Wallis RS, Edmonds K, Okwera A, Mugerwa R, Peters P, Ellner JJ: Depressed T-cell interferon γ responses in pulmonary tuberculosis: analyses of underlying mechanisms and modulation with therapy. J Infect Dis 1999;180:2069-2073.
29. Seah GT, Scott GM, Rook GAW: Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000;181:385-389.
30. + T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis 2002;82:7-13.
31. Turner J, Corrah T, Sabbally S, Whittle H, Dockrell HM: A longitudinal study of in vitro IFNγ production and cytotoxic T cell responses of tuberculosis patients in The Gambia. Tuber Lung Dis 2000;80:161-169.
32. Verbon A, Juffermans N, Van Deventer SJH, Speelman P, Van Deutekom H, Van Der Poll T: Serum concentrations of cytokines in patients with active tuberculosis and after treatment. Clin Exp Immunol 1999;115:110-113.
33. Toossi Z, Kleinhenz ME, Ellner JJ: Defective IL-2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 1986;163:1162-1172.
34. Torres M, Herrera T, Villareal H, Rich EA, Sada E: Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect Immun 1998;66:176-180.
35. Haslam PL, Baughmann RP: Guidelines for measurement of acellular components and recommendations for standardization of bronchoalveolar lavage (BAL). Eur Respir Rev 1999;9:106-112.
36. Reynolds PR, Cosio MG, Hoidal JR: Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol 2006;35:314-319.
37. Kim Y, Kim K, Joe J, Park H, Lee M, Kim Y, Choi Y, Park S: Changes in the levels of interferon-gamma and transforming growth factor-beta influence bronchial stenosis during the treatment of endobronchial tuberculosis. Respiration 2007;74:202-207.
38. Jafari C, Ernst M, Kalsdorf B, Greinert U, Diel R, Kirsten D, Marienferd K, Lalvani A, Lange C: Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immonuspot. Am J Respir Crit Care Med 2006;174:963-964.